trending Market Intelligence /marketintelligence/en/news-insights/trending/stio__y67ig5q8x5pmt57g2 content esgSubNav
In This List

Aurinia Pharmaceuticals appoints director

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Aurinia Pharmaceuticals appoints director

Canada's Aurinia Pharmaceuticals Inc. added Michael Hayden to its board.

Hayden most recently served as president of global research and development and chief scientific officer at Teva Pharmaceutical Industries Ltd.